{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:41:25Z","timestamp":1792190485229,"version":"4.4.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":2048,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jpain.2017.08.009","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T05:46:47Z","timestamp":1506059207000},"page":"125-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Unravelling Fibromyalgia\u2014Steps Toward Individualized Management"],"prefix":"10.1016","volume":"19","author":[{"given":"Winfried","family":"H\u00e4user","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Perrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Clauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Ann","family":"Fitzcharles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2017.08.009_bib0010","first-page":"742","article-title":"Guidelines for the diagnosis and treatment of the fibromyalgia syndrome [in Hebrew]","volume":"152","author":"Ablin","year":"2013","journal-title":"Harefuah"},{"key":"10.1016\/j.jpain.2017.08.009_bib0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4081\/reumatismo.2012.268","article-title":"Psychiatric problems in fibromyalgia: Clinical and neurobiological links between mood disorders and fibromyalgia","volume":"64","author":"Alciati","year":"2012","journal-title":"Reumatismo"},{"key":"10.1016\/j.jpain.2017.08.009_bib0020","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/AJP.0000000000000354","article-title":"Fibromyalgia and chronic pain syndromes: A white paper detailing current challenges in the field","volume":"32","author":"Arnold","year":"2016","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2017.08.009_bib0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/AJP.0b013e318197d4e4","article-title":"Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder","volume":"25","author":"Arnold","year":"2009","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2017.08.009_bib0030","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3899\/jrheum.141196","article-title":"Efficacy and safety of pregabalin in patients with fibromyalgia and comorbid depression taking concurrent antidepressant medication: A randomized, placebo-controlled study","volume":"42","author":"Arnold","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpain.2017.08.009_bib0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jpain.2017.08.009_bib0040","first-page":"S154","article-title":"The Fibromyalgia Impact Questionnaire (FIQ): A review of its development, current version, operating characteristics and uses","volume":"23","author":"Bennett","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jpain.2017.08.009_bib0045","doi-asserted-by":"crossref","DOI":"10.1177\/2156587216659400","article-title":"A Randomized, controlled trial of wholistic hybrid derived from eye movement desensitization and reprocessing and emotional freedom technique (WHEE) for self-treatment of pain, depression, and anxiety in chronic pain patients","author":"Benor","year":"2017","journal-title":"J Evid Based Complementary Altern Med"},{"key":"10.1016\/j.jpain.2017.08.009_bib0050","article-title":"Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome \u2013 A systematic review and meta-analysis of randomized controlled trials","author":"Bernardy","year":"2017","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpain.2017.08.009_bib0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1759720X11416863","article-title":"Simplifying fibromyalgia assessment: The VASFIQ brief symptom scale","volume":"3","author":"Boomershine","year":"2011","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.jpain.2017.08.009_bib0060","author":"Chronic Pain Research Alliance"},{"key":"10.1016\/j.jpain.2017.08.009_bib0065","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: A clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jpain.2017.08.009_bib0070","article-title":"Pregabalin for pain in fibromyalgia in adults","author":"Derry","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpain.2017.08.009_bib0075","doi-asserted-by":"crossref","first-page":"e74873","DOI":"10.1371\/journal.pone.0074873","article-title":"Cluster analysis of clinical data identifies fibromyalgia subgroups","volume":"8","author":"Docampo","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jpain.2017.08.009_bib0080","article-title":"Definition, classification, clinical diagnosis and prognosis of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles","author":"Eich","year":"2017","journal-title":"Schmerz"},{"key":"10.1016\/j.jpain.2017.08.009_bib0085","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1176\/appi.ajp.2013.13111546","article-title":"The global dissemination of psychological treatments: A road map for research and practice","volume":"171","author":"Fairburn","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpain.2017.08.009_bib0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/2013\/918216","article-title":"Canadian guidelines for the diagnosis and management of fibromyalgia syndrome: Executive summary","volume":"18","author":"Fitzcharles","year":"2013","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.jpain.2017.08.009_bib0095","author":"Forte"},{"key":"10.1016\/j.jpain.2017.08.009_bib0100","doi-asserted-by":"crossref","first-page":"962741","DOI":"10.1155\/2013\/962741","article-title":"Efficacy of EMG- and EEG-biofeedback in fibromyalgia syndrome: A meta-analysis and a systematic review of randomized controlled trials","volume":"2013","author":"Glombiewski","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.jpain.2017.08.009_bib0105","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1038\/nrdp.2015.22","article-title":"Fibromyalgia","volume":"1","author":"H\u00e4user","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jpain.2017.08.009_bib0110","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.pain.2013.03.034","article-title":"Posttraumatic stress disorder in fibromyalgia syndrome: Prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome","volume":"154","author":"H\u00e4user","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2017.08.009_bib0115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jpsychores.2014.01.009","article-title":"Patient health questionnaire 15 as a generic measure of severity in fibromyalgia syndrome: Surveys with patients of three different settings","volume":"76","author":"H\u00e4user","year":"2014","journal-title":"J Psychosom Res"},{"issue":"2","key":"10.1016\/j.jpain.2017.08.009_bib0120","article-title":"Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome","author":"H\u00e4user","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpain.2017.08.009_bib0125","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(07)60159-7","article-title":"Management of functional somatic syndromes","volume":"369","author":"Henningsen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jpain.2017.08.009_bib0130","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrcardio.2016.134","article-title":"2016 ESC and ACC\/AHA\/HFSA heart failure guideline update\u2014what is new and why is it important?","volume":"13","author":"Jessup","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jpain.2017.08.009_bib0135","first-page":"1","article-title":"Association of rheumatic diseases with symptom severity, quality of life, and treatment outcome in patients with fibromyalgia","volume":"1","author":"Jiao","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jpain.2017.08.009_bib0140","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00296-014-3113-0","article-title":"Association of abuse history with symptom severity and quality of life in patients with fibromyalgia","volume":"35","author":"Jiao","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jpain.2017.08.009_bib0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1477-7525-4-67","article-title":"A comprehensive review of 46 exercise treatment studies in fibromyalgia (1988\u20132005)","volume":"4","author":"Jones","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jpain.2017.08.009_bib0150","first-page":"1","article-title":"Concomitant fibromyalgia in rheumatoid arthritis is associated with the more frequent use of biological therapy: A cross-sectional study","volume":"1","author":"Lage-Hansen","year":"2015","journal-title":"Scand J Rheumatolm"},{"key":"10.1016\/j.jpain.2017.08.009_bib0155","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00482-010-0937-8","article-title":"Influence of depression on fibromyalgia: A systematic review","volume":"24","author":"Lange","year":"2010","journal-title":"Schmerz"},{"key":"10.1016\/j.jpain.2017.08.009_bib0160","series-title":"Typology of patients with fibromyalgia: Cluster analysis of duloxetine study patients. BMC Musculoskelet Disord","author":"Lipkovich","year":"2014"},{"key":"10.1016\/j.jpain.2017.08.009_bib0165","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s003840100299","article-title":"Fibromyalgia in patients with irritable bowel syndrome. An association with the severity of the intestinal disorder","volume":"16","author":"Lubrano","year":"2001","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.jpain.2017.08.009_bib0170","doi-asserted-by":"crossref","DOI":"10.1097\/j.pain.0000000000001036","article-title":"Emotional awareness and expression therapy, cognitive behavioral therapy, and education for fibromyalgia: a cluster-randomized controlled trial","author":"Lumley","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2017.08.009_bib0175","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jpain.2017.08.009_bib0180","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/j.pain.0000000000000733","article-title":"Identifying patients with chronic widespread pain in primary care","volume":"158","author":"Mansfield","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2017.08.009_bib0185","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/RHU.0000000000000089","article-title":"Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: A review of case-control studies","volume":"20","author":"Mart\u00ednez-Mart\u00ednez","year":"2014","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jpain.2017.08.009_bib0190","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13075-015-0718-y","article-title":"A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients","volume":"17","author":"Murakami","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jpain.2017.08.009_bib0195","first-page":"233","article-title":"Using cognitive behaviour therapy with South Asian Muslims: Findings from the culturally sensitive CBT project","volume":"27","author":"Naeem","year":"2015","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.jpain.2017.08.009_bib0200","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3899\/jrheum.110569","article-title":"An international, randomized, double-blind, placebo controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia","volume":"38","author":"Pauer","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpain.2017.08.009_bib0210","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/ejp.564","article-title":"More ubiquitous effects from non-pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: A meta-analysis examining six core symptoms","volume":"18","author":"Perrot","year":"2014","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpain.2017.08.009_bib0215","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2474-13-22","article-title":"Societal and individual burden of illness among fibromyalgia patients in France: Association between disease severity and OMERACT core domains","volume":"13","author":"Perrot","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jpain.2017.08.009_bib0220","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00482-017-0201-6","article-title":"General treatment principles, coordination of care and patient education in fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles [in German]","volume":"31","author":"Petzke","year":"2017","journal-title":"Schmerz"},{"key":"10.1016\/j.jpain.2017.08.009_bib0225","first-page":"726","article-title":"Self-reported physical health, mental health, and comorbid diseases among women with irritable bowel syndrome, fibromyalgia, or both compared with healthy control respondents","volume":"112","author":"Przekop","year":"2012","journal-title":"J Am Osteopath Assoc"},{"key":"10.1016\/j.jpain.2017.08.009_bib0230","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/art.24430","article-title":"Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis","volume":"61","author":"Ranzolin","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpain.2017.08.009_bib0235","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/rheumatology\/keq066","article-title":"A cross-sectional survey of 3035 patients with fibromyalgia: Subgroups of patients with typical comorbidities and sensory symptom profiles","volume":"49","author":"Rehm","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jpain.2017.08.009_bib0240","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00296-014-3029-8","article-title":"Classifying fibromyalgia patients according to severity: The combined index of severity in fibromyalgia","volume":"34","author":"Rivera","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jpain.2017.08.009_bib0245","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1477-7525-9-71","article-title":"The comparative burden of mild, moderate and severe fibromyalgia: Results from a cross-sectional survey in the United States","volume":"9","author":"Schaefer","year":"2011","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jpain.2017.08.009_bib0250","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jpain.2016.12.006","article-title":"Evidenced-based guidelines on the treatment of fibromyalgia patients: Are they consistent and if not, why not? Have effective psychological treatments been overlooked?","volume":"18","author":"Thieme","year":"2017","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2017.08.009_bib0255","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jpain.2014.11.009","article-title":"The relationship among psychological and psychophysiological characteristics of fibromyalgia patients","volume":"16","author":"Thieme","year":"2015","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2017.08.009_bib0260","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.genhosppsych.2013.07.014","article-title":"Personality does not distinguish people with fibromyalgia but identifies subgroups of patients","volume":"35","author":"Torres","year":"2013","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.jpain.2017.08.009_bib0265","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/1359105315611957","article-title":"Post-traumatic stress disorder symptoms may explain poor mental health in patients with fibromyalgia","volume":"22","author":"Toussaint","year":"2017","journal-title":"J Health Psychol"},{"key":"10.1016\/j.jpain.2017.08.009_bib0270","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/art.1790110511","article-title":"Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatment","volume":"11","author":"Turk","year":"1998","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jpain.2017.08.009_bib0275","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00482-017-0202-5","article-title":"Etiology and pathophysiology of fibromyalgia syndrome : Updated guidelines 2017, overview of systematic review articles and overview of studies on small fiber neuropathy in FMS subgroups [in German]","volume":"31","author":"\u00dc\u00e7eyler","year":"2017","journal-title":"Schmerz"},{"key":"10.1016\/j.jpain.2017.08.009_bib0280","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2474-12-245","article-title":"Systematic review with meta-analysis: Cytokines in fibromyalgia syndrome","volume":"12","author":"\u00dc\u00e7eyler","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"issue":"10","key":"10.1016\/j.jpain.2017.08.009_bib0285","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010782","article-title":"Anticonvulsants for fibromyalgia","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpain.2017.08.009_bib0290","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/acr.20268","article-title":"Tailored cognitive-behavioral therapy and exercise training for high-risk patients with fibromyalgia","volume":"62","author":"van Koulil","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jpain.2017.08.009_bib0295","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/s13075-014-0463-7","article-title":"OMERACT-based fibromyalgia symptom subgroups: An exploratory cluster analysis","volume":"16","author":"Vincent","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jpain.2017.08.009_bib0300","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.pain.2014.04.032","article-title":"Short-term improvement in insomnia symptoms predicts long-term improvements in sleep, pain, and fatigue in older adults with comorbid osteoarthritis and insomnia","volume":"155","author":"Vitiello","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2017.08.009_bib0305","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/art.24163","article-title":"Toward the identification of symptom patterns in people with fibromyalgia","volume":"61","author":"Wilson","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpain.2017.08.009_bib0310","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jpain.2017.08.009_bib0315","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR preliminary diagnostic criteria for fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpain.2017.08.009_bib0320","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jpain.2017.08.009_bib0325","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/acr.22742","article-title":"Comparison of physician-based and patient-based criteria for the diagnosis of fibromyalgia","volume":"68","author":"Wolfe","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jpain.2017.08.009_bib0330","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpain.2017.08.009_bib0335","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3899\/jrheum.141519","article-title":"The use of polysymptomatic distress categories in the evaluation of fibromyalgia (FM) and FM severity","volume":"42","author":"Wolfe","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpain.2017.08.009_bib0340","first-page":"584573","article-title":"The prevalence of fibromyalgia in other chronic pain conditions","volume":"2012","author":"Yunus","year":"2012","journal-title":"Pain Res Treat"},{"key":"10.1016\/j.jpain.2017.08.009_bib0345","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ejp.933","article-title":"Efficacy, tolerability and safety of guided imagery\/hypnosis in fibromyalgia","volume":"21","author":"Zech","year":"2017","journal-title":"Eur J Pain"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590017307009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590017307009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T23:57:38Z","timestamp":1694908658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590017307009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1526590017307009"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2017.08.009","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unravelling Fibromyalgia\u2014Steps Toward Individualized Management","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2017.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Pain Society","name":"copyright","label":"Copyright"}]}}